Shandong Sinobioway Biomedicine Co., Ltd.

SZSE:002581.SZ

15.12 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -322.135-0.868278.689-198.17773.084-92.557392.205416.515240.30381.47988.03786.27166.97670.25658.82437.04332.633
Depreciation & Amortization 70.63374.8665.959.68257.99459.24750.94455.27142.4112.6547.3127.4327.9157.4758.0336.5333.886
Deferred Income Tax 5.54812.445-0.194-3.587-0.2233.1915.456-29.56-1.27300000000
Stock Based Compensation 15.4290000000000000000
Change In Working Capital 66.38367.26566.029171.5169.248-15.608-131.536-294.273-157.538-11.547-13.691-30.686-1.3787.188-14.4831.993-10.56
Accounts Receivables 69.75746.78875.083106.22649.47118.456-127.562-195.2-163.881-107.704-46.014-12.84800000
Inventory -15.162-16.1356.534-4.377-11.29317.6695.5860.0528.424-6.476-3.223-14.1172.328-2.8715.858-1.225-4.067
Accounts Payables 6.24124.167-15.39373.253-28.706-70.962-15.017-69.564-0.80800000000
Other Working Capital 15.512.445-0.194-3.587-0.223-33.278-137.122-294.324-165.962-5.071-10.468-16.569-3.70510.059-20.3413.218-6.492
Other Non Cash Items 13.44-195.742-456.634-14.51-91.912123.375-40.506-8.19812.554-2.4771.4740.0190.9130.7941.6831.319-0.892
Operating Cash Flow -36.506-54.485-46.01518.5148.41574.456271.107169.315137.72980.10883.13363.03574.42785.71254.05746.88825.068
Investing Activities:
Investments In Property Plant And Equipment -4.319-31.464-60.846-67.697-36.274-608.267-88.132-44.687-45.615-20.594-42.404-62.113-27.149-29.674-15.628-31.115-5.91
Acquisitions Net 4.77224.450.0160.2330.3520.6060.3830.4450.001-32.5270000000
Purchases Of Investments 0-50-5.016-60.514-20-155.639-26-80055.2810000000
Sales Maturities Of Investments 256.19622546.0792.1773000000.7720000000
Other Investing Activites 260.968-3.4015.01675-12.32-1500.3830.445543.165-20.5940.562.262-27.1495.2210.38-31.1152.218
Investing Cash Flow 256.649-38.415-55.829-6.899-66.065-613.299-113.75-124.241497.55-17.663-41.844-59.851-27.149-24.453-15.248-31.115-3.692
Financing Activities:
Debt Repayment -133.162-229-188-875.12-530-100.5-15.45-162.65-302.475-84.268-47.037-19.412-20-40-40-200
Common Stock Issued 00000000000000000
Common Stock Repurchased 00000000000000000
Dividends Paid -10.275-8.042-6.707-55.347-60.393-75.531-0.051-37.086-16.879-70.382-54.14-54.14-43.746-23.568-46.303-17.076-12.039
Other Financing Activities -67.704284.935200.198142.017126.817444.204901.83150187.53478.368169.63355.031469.68638.9844051.1410
Financing Cash Flow -211.14147.8935.492-788.45-463.577268.173886.33-149.736-131.82-76.282-54.14-54.14405.94-24.584-46.30314.065-12.039
Other Information:
Effect Of Forex Changes On Cash -00.004-0.0010.010.0010.0030.0070.044-0.0570.00500000-0-0
Net Change In Cash 9.001-45.003-96.354-776.829-481.226-270.6671,043.693-104.618503.401-13.836-12.852-50.956453.21836.675-7.49529.8389.337
Cash At End Of Period 151.795142.794187.797284.1511,060.981,542.1261,812.793769.099873.718453.863467.699480.551531.50678.28841.61449.10819.27